Hdt Bio

HDT Bio is a biotechnology company specializing in developing immunotherapies and vaccines. They generate revenue through partnerships, grants, and licensing their proprietary RNA platform technology. Founded in 2019, HDT Bio has rapidly advanced in the biotech sector, notably contributing to COVID-19 vaccine development. Their innovative approach focuses on harnessing the body's immune system to combat infectious diseases and cancer, positioning them as a key player in the global health landscape.

Recent Posts by Hdt Bio

1-1 of 1